Looks to me like PRG must think there is some real value in what they are buying here. As part of the deal they have to pay Than $720,000 and 4.8 million shares. That in addition to whatever other terms are a part of this merger. Seems like a steep price. If their only ambition was to go public, they could have bought a cheap shell and merged into it.
$15 million in revenue is not earth shaking, but nice for an OTC company. They are also assuming a lot of debt. If they are running a profitable company, they must have a good handle on business management.
This could be the start of a growing prosperous business.
News 
Market Data 
Discover 
